作为阿尔茨海默病标志物的局部用托吡卡胺的瞳孔反应。
Pupillary response to topical tropicamide as a marker for Alzheimer's disease.
作者信息
Treloar A J, Assin M, Macdonald A J
机构信息
Division of Psychiatry, United Medical and Dental Schools (Guy's), Bexley Hospital, Kent, UK.
出版信息
Br J Clin Pharmacol. 1996 Mar;41(3):256-7. doi: 10.1111/j.1365-2125.1996.tb00194.x.
Abstract
The mydriatic response to eyedrops of the anticholinergic drug tropicamide at very low concentration (0.01%) was studied in subjects with Alzheimer's disease (AD, n = 10) and multi-infarct dementia (MID, n = 10). There was no significant difference in pupillary response between the two groups. The test is unlikely to be useful in differentiating different types of dementia.
摘要
在患有阿尔茨海默病（AD，n = 10）和多发梗死性痴呆（MID，n = 10）的受试者中，研究了极低浓度（0.01%）的抗胆碱能药物托吡卡胺滴眼液的散瞳反应。两组之间的瞳孔反应没有显著差异。该测试不太可能用于区分不同类型的痴呆。
Zotero 插件